Aquinox Pharmaceuticals (AQXP): Dumped By Big Pharmas – ValueWalk Premium
Aquinox

Aquinox Pharmaceuticals (AQXP): Dumped By Big Pharmas

Johnson & Johnson and Pfizer both pruned their holdings in Aquinox Pharmaceuticals following the recent run-up in its shares.

Aquinox Pharmaceuticals (AQXP) soared recently after the company announced positive results from secondary endpoints from its Phase 2 LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).


Aquinox’s improved quarterly earnings
As outlined by ValueWalk, Aquinox Pharmaceuticals unveiled its second quarter results wherein the clinical stage . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0